CellaVision
247,5 SEK -3,51%1.502 investorer følger denne virksomhed
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Omsætning
677,29 mio.
EBIT %
24,66 %
P/E
45,33
Udbytteafkast, %
0,91 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CEVI
Daglig lav / høj pris
241 / 257
SEK
Markedsværdi
5,9 mia. SEK
Aktieomsætning
2,6 mio. SEK
Volumen
11 t
Seneste videoer
Finanskalender
Årsrapport
06.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
William Demant Invest | 19,9 % | 19,9 % |
Grenlunden CEVI AB | 10,0 % | 10,0 % |
SEB Fonder | 9,2 % | 9,2 % |
Christer Fåhraeus o bol | 6,8 % | 6,8 % |
Swedbank Robur fonder | 5,4 % | 5,4 % |
Invesco | 3,8 % | 3,8 % |
Fjärde AP-fonden | 3,0 % | 3,0 % |
Handelsbanken Fonder | 2,9 % | 2,9 % |
La Financière de l'Echiquier | 2,6 % | 2,6 % |
AMF Pension & Fonder | 2,5 % | 2,5 % |
ViserAlle indholdstyper
CellaVision, Audiocast with teleconference, Q3'24
Strong Sales in EMEA Amid Market Uncertainties in the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools